Novo Nordisk (Novo) is one of the world’s leading global pharmaceutical companies, manufacturing medicines for chronic diseases such as diabetes and obesity, and delivering them to patients across many countries. Behind every product lies a manufacturing network that adheres to strict quality requirements. Every quality-relevant process step must be described, controlled, and validated through formal documentation. Keeping this documentation current and accurate is a core responsibility of the Manufacturing Technology team within the Tablet area, a responsibility that spans a large and diverse portfolio of controlled documents, including standard operating procedures, work instructions, forms, and training materials, across the global organization.
Managing this portfolio presents significant challenges. Document updates are frequent, driven by regulatory changes, process improvements, equipment modifications, and audit findings. Each update demands careful review, structured approval workflows, and timely communication to all affected stakeholders. With thousands of active documents spread across multiple divisions, departments, and product programs, tracking which documents are due for revision, pending approval, or require immediate attention becomes increasingly complex. Much of this oversight currently relies on manual processes and fragmented tracking methods such as spreadsheets or disconnected systems. These methods are time-consuming, error-prone, and difficult to scale. The result is a risk of outdated documentation remaining in circulation, delayed updates, and critical gaps in compliance visibility.
Beyond document management, there is a deeper knowledge challenge. Valuable manufacturing knowledge is distributed across many controlled documents, versions, sites, and product programs. Finding the right answer at the right time often depends on experienced individuals knowing where to look.
Source link







